The Association of the British Pharmaceutical Industry
Medicines are transforming our lives like never before.
We want the UK to be the best place in the world to research, develop and use the medicines and vaccines of the future.
Pharma Impact Map
ABPI has published an interactive Pharma Impact Map, demonstrating the value of the pharmaceutical industry in different regional areas of all the four nations of the UK, down to constituency level. Data is available on economic value, manufacturing sites, jobs, NHS/industry collaborations, and research.
Partnering with purpose: How integrated care systems and industry can work better together
The NHS Confederation and the ABPI have published a joint report on how Integrated Care Systems (ICSs) and industry can work better together in the interests of patients.
NHS Industry Case Studies Library
Partnerships between the NHS and the pharmaceutical industry benefit patients and the NHS. Visit the ABPI's library of case studies of successful partnerships.
WTO Ministerial Conference in Abu Dhabi an opportunity to strengthen trade and health agenda
Joint industry associations statement on the meeting of global trade ministers at the World Trade Organization’s 13th Ministerial Conference in Abu Dhabi (MC13).
How to make sure patients get faster and fairer access to new medicines
In a new report, the ABPI's Patient Advisory Council says that UK governments and NHS leaders need to start with a holistic view of patient need and improve fair access to the latest medical advances.
UK life science industry sets out priorities for the Budget
The Association of the British Pharmaceutical Industry (ABPI) has set out the measures the UK’s life sciences industry wants to see in Chancellor Jeremy Hunt’s Budget on Wednesday, 6 March.
ABPI statement on brain tumour research
The ABPI has responded to recent concerns from a charity that pharmaceutical companies are holding up brain tumour research.
Latest blogs and events
Leaving no one behind: The current measles outbreak demonstrates the importance of the NHS vaccination strategy
Vaccination is the best line of defence against disease outbreaks. The NHS vaccination strategy will make it easier for people to be protected in the future, says ABPI Medical Director Dr Amit Aggarwal.
Reinventing Reputation: one of pharma's biggest challenges
Blog post by Seyda Atadan Memis, Takeda General Manager UK & Ireland and ABPI Reputation Board Sponsor
What the pandemic taught us about international trade rules for health - and how we can make them better for the future
Blog post by Ben Lucas, Managing Director, MSD UK & Ireland and ABPI Board Sponsor, International and Intellectual Property Policy
NICE/DSU/ABPI Masterclass – What makes a good submission to NICE?
NICE and the ABPI invite you to the first event in the NICE/DSU/ABPI Masterclass Programme in 2024 - What makes a good submission to NICE?
Key content hubs
The COP28 summit will bring parties together to accelerate action towards the goals of the Paris Agreement and the UN Framework Convention on Climate Change.
As a critical part of the health care community in the UK, the pharmaceutical industry wants to play the biggest possible role in the response to COVID-19.
The ABPI Code of Practice sets out the requirements the industry must comply with and supports companies’ commitment to self-regulation and to operate in a professional, ethical and transparent manner.